UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | J | K | L | M | P | R | S | T | W
Number of items: 62.

A

Agbamu, DA; Day, N; Walsh, CJ; Hendrickse, CW; Langman, G; Pallan, A; Lowe, A; (2012) Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: The pilot phase of a randomised controlled trial. The Lancet Oncology , 13 (11) 1152 - 1160. 10.1016/S1470-2045(12)70348-0. Green open access
file

Allen, TJ; Hall, A; Dhillon, AP; Owen, JS; Beard, PC; (2012) Spectroscopic photoacoustic imaging of lipid-rich plaques in the human aorta in the 740 to 1400 nm wavelength range. J Biomed Opt , 17 (6) 061209-. 10.1117/1.JBO.17.6.061209.

Arrieta Bolanos, ER; Madrigal, J; Shaw, B; (2012) Functional consequences of TGFB1 polymorphisms in regulatory T cells and haematopoietic stem cell transplantation. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; (2012) Human Leukocyte Antigen Profiles of Latin American Populations: Differential Admixture and Its Potential Impact on Hematopoietic Stem Cell Transplantation. Bone Marrow Research , 2012 , Article 136087. 10.1155/2012/136087. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; Marsh, SGE; Salazar-Sánchez, L; (2012) The frequency of HLA-B*57:01 and the risk of Abacavir hypersensitivity reactions in the Costa Rica Central Valley Population. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) FUNCTIONAL CONSEQUENCES OF TGFB1 POLYMORPHISMS IN REGULATORY T CELLS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION. Presented at: UNSPECIFIED. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) Transforming growth factor-ss 1 polymorphisms and the outcome of hematopoietic stem cell transplantation. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 192-202. 10.1111/j.1744-313X.2012.01089.x.

B

BENJAMIN, R; (2012) Antiangiogenic strategies for the treatment of haematological malignancies. Doctoral thesis, UCL (University College London). Green open access
file

Becerra, E; de la Torre, I; Leandro, MJ; Heelas, EO; Westwood, J-P; Scully, M; Cambridge, G; (2012) B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) EXPRESSION AFTER RITUXIMAB: COMPARISON OF PATIENTS WITH RHEUMATOID ARTHRITIS AND THROMBOTIC THROMBOCYTOPENIC PURPURA. ANNALS OF THE RHEUMATIC DISEASES , 71 pp. 488-489.

Bez, C.; (2012) The role of the telomere bouquet in controlling spindle pole body composition in fission yeast meiosis. Doctoral thesis, UCL (University College London). Green open access
file

Bhosle, J.; (2012) Modulation of DNA strand break induction and repair by tyrosine kinase inhibitors targeted against EGFR and HER2. Doctoral thesis, UCL (University College London). Green open access
file

Boshoff, C; (2012) Ephrin receptor: a door to KSHV infection. Nat Med , 18 (6) pp. 861-863. 10.1038/nm.2803.

Bridge, G; Monteiro, R; Henderson, S; Emuss, V; Lagos, D; Georgopoulou, D; Patient, R; (2012) The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood , 120 (25) pp. 5063-5072. 10.1182/blood-2012-04-423004.

Brown, N.J.; (2012) Characterisation of the centrosome protein Cep63. Doctoral thesis, UCL (University College London). Green open access
file

C

Calvaruso, V; Dhillon, AP; Tsochatzis, E; Manousou, P; Grillo, F; Germani, G; Patch, D; (2012) Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation. J Gastroenterol Hepatol , 27 (7) pp. 1227-1232. 10.1111/j.1440-1746.2012.07136.x.

Canzonetta, C; Hoischen, A; Giarin, E; Basso, G; Veltman, JA; Nacheva, E; Nizetic, D; (2012) Amplified segment in the 'Down syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2. Br J Haematol , 157 (2) pp. 197-200. 10.1111/j.1365-2141.2011.08985.x.

Carpenter, B; Ghorashian, S; Nicholson, E; Griffin, JE; Ahmadi, M; Holler, A; Flutter, B; (2012) Targeting Therapeutic T Cells to Tumour Niches. Presented at: UNSPECIFIED.

Cohen, H; Mackie, IJ; Westwood, JP; Chitolie, A; Liesner, R; Machin, SJ; (2012) Prothrombin/phosphatidyl serine antibodies in patients with antiphospholipid antibodies. In: (pp. pp. 33-34).

D

Dignan, FL; (2012) Novel strategies for managing graft-versus-host disease. Doctoral thesis, UCL (University College London).

E

El-Sharkawi, D; Ali, A; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2012) ASXL1 mutations are infrequent in young patients with primary acute myeloid leukaemia. In: (pp. p. 56).

El-Sharkawi, D; Basu, S; Ocampo, C; Qian, W; D'Sa, S; Hoskin, PJ; Ardeshna, KM; (2012) Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy. Leuk Lymphoma , 53 (10) pp. 1949-1952. 10.3109/10428194.2012.679360.

El-Sharkawi, D; Fisher, C; Khambadkone, S; Stephens, AD; Porter, JB; (2012) Secondary erythrocytosis due to compound homozygosity, but not compound heterozygosity, for Hb Luton and α-thalassemia: a family study. Hemoglobin , 36 (1) pp. 7-17. 10.3109/03630269.2011.641134.

G

Gooding, M; Tudzarova, S; Worthington, RJ; Kingsbury, SR; Rebstock, AS; Dube, H; Simone, MI; (2012) Exploring the interaction between siRNA and the SMoC biomolecule transporters: implications for small molecule-mediated delivery of siRNA. Chem Biol Drug Des , 79 (1) pp. 9-21. 10.1111/j.1747-0285.2011.01249.x.

Grace, C; Nacheva, EP; (2012) Significance Analysis of Microarrays (SAM) Offers Clues to Differences Between the Genomes of Adult Philadelphia Positive ALL and the Lymphoid Blast Transformation of CML. Cancer Inform , 11 pp. 173-183. 10.4137/CIN.S9258. Gold open access

Green, L; Lawrie, AS; Patel, R; Stephens, RC; Mackie, IJ; Chitolie, A; Haddad, FS; (2012) The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters. Thromb Res , 130 (5) pp. 775-779. 10.1016/j.thromres.2011.12.023.

Green, L; Safa, O; Machin, SJ; Mackie, IJ; Ryland, K; Cohen, H; Lawrie, AS; (2012) Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway. Thromb Res , 130 (5) pp. 780-784. 10.1016/j.thromres.2011.12.034.

Griffin, JE; Carpenter, B; Nicholson, E; Xue, S-A; Pule, M; Stauss, H; Chakraverty, R; (2012) In Vivo Selection of Mycophenolate Mofetil-Resistant T Cells for Adoptive Immunotherapy. In: BLOOD.

H

Hall, A; Germani, G; Isgrò, G; Burroughs, AK; Dhillon, AP; (2012) Fibrosis distribution in explanted cirrhotic livers. Histopathology , 60 (2) pp. 270-277. 10.1111/j.1365-2559.2011.04094.x.

He, M; Bakken, T; Kassimova, A; Boshoff, C; Philpott, N; Cannon, ML; (2012) Focal adhesion kinase is required for KSHV vGPCR signaling. Mol Carcinog , 51 (4) pp. 339-351. 10.1002/mc.20790.

Hergovich, A; (2012) Mammalian Hippo signalling: a kinase network regulated by protein-protein interactions. Biochem Soc Trans , 40 (1) pp. 124-128. 10.1042/BST20110619. Gold open access

Hergovich, A; (2012) YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer. Breast Cancer Res , 14 (6) 326-. 10.1186/bcr3349.

Hergovich, A; Hemmings, BA; (2012) Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways. Semin Cell Dev Biol , 23 (7) pp. 794-802. 10.1016/j.semcdb.2012.04.001. Gold open access

Hytiroglou, P; Snover, DC; Alves, V; Balabaud, C; Bhathal, PS; Bioulac-Sage, P; Crawford, JM; (2012) Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol , 137 (1) pp. 5-9. 10.1309/AJCP2T2OHTAPBTMP.

J

Jenkinson, S; Koo, K; Goulden, N; Vora, A; Mitchell, C; Wade, R; Richards, SM; (2012) Presence of mutations in the NOTCH1 signalling pathway has a beneficial impact on outcome in paediatric T-ALL patients treated on the MRC UKALL2003 trial. Presented at: UNSPECIFIED.

K

Kelly, JD; Dudderidge, TJ; Wollenschlaeger, A; Okoturo, O; Burling, K; Tulloch, F; Halsall, I; (2012) Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22. PLOS One , 7 (7) , Article e40305. 10.1371/journal.pone.0040305. Green open access
file

L

Lawrie, AS; Hills, J; Longair, I; Green, L; Gardiner, C; Machin, SJ; Cohen, H; (2012) The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. Thromb Res , 130 (1) pp. 110-114. 10.1016/j.thromres.2011.08.027.

Lawrie, AS; Pizzey, A; Trompeter, S; Meiselman, H; Mohandas, N; Dumanski, JP; Westerman, MP; (2012) Procoagulant activity in patients with sickle cell trait. Blood Coagul Fibrinolysis , 23 (4) pp. 268-270. 10.1097/MBC.0b013e32835187f8.

Lechner, M; (2012) Genomic and Epigenomic Analysis of HPV positive and HPV negative Head and Neck Squamous Cell Cancer. Doctoral thesis, UCL (University College London). Green open access
file

Lee, S; Upadhyay, S; Lewanski, C; Falk, S; Skailes, G; Marshall, E; Ngai, Y; (2012) TOPICAL: RANDOMIZED PHASE III TRIAL OF ERLOTINIB COMPARED WITH PLACEBO IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) UNSUITABLE FOR FIRST-LINE CHEMOTHERAPY: UPDATED ANALYSIS. In: ANNALS OF ONCOLOGY. (pp. 421 - 421).

Lee, SM; Khan, I; Upadhyay, S; Lewanski, C; Falk, S; Skailes, G; Marshall, E; (2012) First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol , 13 (11) pp. 1161-1170. 10.1016/S1470-2045(12)70412-6. Gold open access

M

Manousou, P; Burroughs, AK; Tsochatzis, E; Isgro, G; Hall, AR; Green, AC; Calvaruso, V; (2012) Assessment of progression of fibrosis in recurrent HCV after liver transplantation by digital image analysis of collagen. In: (pp. 528A-528A).

Manousou, P; Tsianou, Z; Burroughs, AK; Dhillon, AP; Hall, AR; Tzallas, AT; Bai, AP; (2012) Digital image analysis of collagen for chronic Hepatitis B patients. Should we follow the treatment guidelines? In: (pp. 411A-412A).

Manousou, P; Tsochatzis, E; Hall, AR; Thalassinos, E; Papastergiou, V; Rodriguez-Peralvarez, M; Germani, G; (2012) Antiviral treatment in HCV post LT modulates fibrosis progression evaluated by CPA regardless of achieving SVR. In: (pp. 532A-533A).

Marzolini, M; Wong, WL; Ardeshna, K; Padhani, A; D'Sa, S; (2012) Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. Br J Haematol , 156 (5) 557-. 10.1111/j.1365-2141.2011.08959.x.

Mohamed, F; Dhar, D; Shah, N; Davies, N; Habtesion, A; Luong, T; Winstanley, A; (2012) TLR7 EXPRESSION IS INCREASED IN HEPATOCELLULAR CANCER (HCC) AND ITS MODULATION IS ASSOCIATED WITH ALTERATIONS IN TUMOUR GROWTH: A NOVEL THERAPEUTIC TARGET. GUT , 61 A110-A111. 10.1136/gutjnl-2012-302514b.92.

Mohamed, F; Dhar, D; Shah, N; Davies, N; Habtesion, A; Luong, TV; Winstanley, A; (2012) SELECTIVE GUT DECOMTAMINATION REDUCES HEPATIC EXPRESSION OF TOLL-LIKE RECEPTOR (TLR) 4 AND DEVELOPMENT OF CIRRHOSIS BUT DOES NOT PREVENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC). GUT , 61 A196-A196. 10.1136/gutjnl-2012-302514c.30.

Mohamed, F; Minogue, S; Shah, N; Davies, N; Habtesion, A; Luong, T; Winstanley, A; (2012) TLR 9 INHIBITION: A NOVEL TARGET OF THERAPY FOR PRIMARY LIVER CANCER. GUT , 61 A110-A110. 10.1136/gutjnl-2012-302514b.91.

Mohamed, FEZ; Dhar, D; Shah, N; Davies, N; Habtesion, A; Luong, TV; Winstanley, A; (2012) SELECTIVE GUT DECOMTAMINATION REDUCES HEPATIC EXPRESSION OF TOLL-LIKE RECEPTOR (TLR) 4 AND DEVELOPMENT OF CIRRHOSIS BUT DOES NOT PREVENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC). In: (pp. S121-S121).

Mohamed, FEZ; Minogue, S; Dhar, D; Shah, N; Davies, N; Habtesion, A; Luong, TV; (2012) TLR 9 INHIBITION: A NOVEL TARGET OF THERAPY FOR PRIMARY LIVER CANCER. In: (pp. S121-S121).

P

Prieto Hinojosa, AI; (2012) T cell subsets and the outcome of haematopoietic stem cell transplantation. Doctoral thesis, UCL (University College London). Green open access
file

R

Rallapalli, P; Gomez, K; Tuddenham, E; Perkins, S; (2012) Phenotypic classification of the mutations in coagulation factor IXx segregate to different locations in its protein structure. HAEMOPHILIA , 18 187 - 187.

Rodríguez-Perálvarez, M; Germani, G; Tsochatzis, E; Rolando, N; Luong, TV; Dhillon, AP; Thorburn, D; (2012) Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count. Transpl Int , 25 (5) pp. 555-563. 10.1111/j.1432-2277.2012.01457.x.

Ryland, JK; Lawrie, AS; Mackie, IJ; Machin, SJ; (2012) Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study. Thromb Res , 129 (4) pp. 447-452. 10.1016/j.thromres.2011.07.020.

S

Shepherd, C; Banerjee, L; Cheung, CW; Mansour, MR; Jenkinson, S; Gale, RE; Khwaja, A; (2012) PI3K/mTOR Inhibition Upregulates NOTCH-MYC Signalling Leading to an Impaired Cytotoxic Response. Presented at: UNSPECIFIED.

Sidor, C.M.; (2012) Mask proteins are co-factors of Yorkie/YAP in the Hippo signaling pathway. Doctoral thesis, UCL (University College London). Green open access
file

Skelton, S; Moss, D; Sansom, C; Gomez, K; Shepherd, A; Hart, D; (2012) Novel MHC-PEPTIDE-T cell receptor interfaces are necessary for inhibitor formation in mild/moderate hemophilia A secondary to missense mutation genotypes. HAEMOPHILIA , 18 86 - 86.

Skelton, S; Moss, D; Sansom, C; Gomez, K; Shepherd, AJ; Hart, DP; (2012) Novel MHC-peptide-T cell receptor interfaces are necessary for inhibitor formation in mild/moderate haemophilia A secondary to missense mutation genotypes. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 10 - 10).

T

Tsochatzis, E; Hall, AR; Manousou, P; Rodriguez-Peralvarez, M; Germani, G; Gale, J; Burgess, GC; (2012) Decompensation occurs at different quantity of fibrosis depending on aetiology of liver disease in patients with cirrhosis. In: (pp. 944A-945A).

Tsochatzis, E; Hall, AR; Rodriguez-Peralvarez, M; Manousou, P; Germani, G; Gale, J; Burgess, GC; (2012) Histological sub-classification of HCV-related cirrhosis with morphometric quantification of liver collagen using collagen proportionate area (CPA). In: (pp. 941A-941A).

Tsochatzis, EA; Manousou, P; Dhillon, AP; Burroughs, AK; (2012) Regression of fibrosis: the need for quantitative methods of assessment. J Hepatol , 57 (6) 1391-. 10.1016/j.jhep.2012.06.039.

W

Westrop, SJ; Lagos, D; Boshoff, C; Bower, M; Imami, N; (2012) African ancestry and innate immunity contribute to the incidence of multicentric Castleman's disease in HIV-1/Kaposi's sarcoma herpesvirus-coinfected individuals. FUTURE VIROLOGY , 7 (7) pp. 729-734. 10.2217/FVL.12.54.

Williams, GH; Stoeber, K; (2012) The cell cycle and cancer. J Pathol , 226 (2) pp. 352-364. 10.1002/path.3022.

This list was generated on Sun Aug 21 09:11:13 2016 BST.